Correction: Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma

Gene Ther. 2023 Jun;30(6):541. doi: 10.1038/s41434-023-00397-y.

Á J De la Rosa¹, Á Rodríguez-Hernández¹, R González², S Romero-Brufau³, E Navarro-Villarán¹, L Barrera-Pulido⁴, S Pereira¹, L M Marín⁴, F López-Bernal⁴, J M Álamo^{4

5}, M A Gómez-Bravo^{4

5}, F J Padillo^{4

5}, J Muntané^{6

7}

¹ Oncology Surgery, Cell Therapy and Transplant Organs, Institute of Biomedicine of Seville (IBiS), 'Virgen del Rocío'-'Virgen Macarena' University Hospital/Universidad de Sevilla/CSIC, Sevilla, Spain.
² Department of Biochemistry and Molecular Biology, University of Cordoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
³ Mayo Clinic College of Medicine, Rochester, MN, USA.
⁴ Department of General Surgery, "Virgen del Rocío"-"Virgen Macarena" University Hospital/IBiS/CSIC/Universidad de Sevilla, Sevilla, Spain.
⁵ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREH o Ciberehd), Instituto de Salud Carlos III, Madrid, Spain.
⁶ Department of General Surgery, "Virgen del Rocío"-"Virgen Macarena" University Hospital/IBiS/CSIC/Universidad de Sevilla, Sevilla, Spain. jmuntane-ibis@us.es.
⁷ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREH o Ciberehd), Instituto de Salud Carlos III, Madrid, Spain. jmuntane-ibis@us.es.

No abstract available

Publication types